Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Felix Sahm

Showing results (301-310 of 451) with videos related to

Pageof 46
Sort By:
Theranostics|October 14, 2021
Tryptophan metabolism is inversely regulated in the tumor and blood of patients with glioblastomaVerena Panitz, Saša Končarević, Ahmed Sadik, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 25, 2013
mTOR target NDRG1 confers MGMT-dependent resistance to alkylating chemotherapyMarkus Weiler, Jonas Blaes, Stefan Pusch, et al.
Clinical and Translational Medicine|July 15, 2022
Functional genomic analysis of epithelioid sarcoma reveals distinct proximal and distal subtype biologySamuel V Rasmussen, Jia Xiang Jin, Lissett R Bickford, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 4, 2025
Availability and use of PET in patients with brain tumours - a European Organisation for Research and Treatment of Cancer - Brain Tumour Group (EORTC-BTG) surveyMaximilian J Mair, Philipp Lohmann, Norbert Galldiks, et al.
Neuro-Oncology|May 27, 2025
Postoperative radiotherapy in subtotally resected recurrent WHO grade 1 meningiomas with intermediate-/high-risk molecular profilesMaximilian Y Deng, Sybren L N Maas, Günes Anil, et al.
Nature|July 22, 2014
A vaccine targeting mutant IDH1 induces antitumour immunityTheresa Schumacher, Lukas Bunse, Stefan Pusch, et al.
Neuropathology and Applied Neurobiology|November 20, 2021
Implementation of TERT promoter mutations improve prognostication of the WHO classification in meningiomaChristian Mirian, Kathrine Grell, Tareq A Juratli, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 23, 2019
Cytotoxic T Cells and their Activation Status are Independent Prognostic Markers in MeningiomasCarmen Rapp, Steffen Dettling, Fang Liu, et al.
Neuro-Oncology|June 5, 2024
Risk factors for domain-specific neurocognitive outcome in pediatric survivors of a brain tumor in the posterior fossa-Results of the HIT 2000 trialMartin Mynarek, Anne Rossius, Anika Guiard, et al.
Neuro-Oncology Advances|June 9, 2023
Analysis of recurrence probability following radiotherapy in patients with CNS WHO grade 2 meningioma using integrated molecular-morphologic classificationMaximilian Y Deng, Felix Hinz, Sybren L N Maas, et al.
Pageof 46

Showing results (301-310 of 451) with videos related to

Sort By:
Pageof 46
Theranostics|October 14, 2021
Tryptophan metabolism is inversely regulated in the tumor and blood of patients with glioblastomaVerena Panitz, Saša Končarević, Ahmed Sadik, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 25, 2013
mTOR target NDRG1 confers MGMT-dependent resistance to alkylating chemotherapyMarkus Weiler, Jonas Blaes, Stefan Pusch, et al.
Clinical and Translational Medicine|July 15, 2022
Functional genomic analysis of epithelioid sarcoma reveals distinct proximal and distal subtype biologySamuel V Rasmussen, Jia Xiang Jin, Lissett R Bickford, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 4, 2025
Availability and use of PET in patients with brain tumours - a European Organisation for Research and Treatment of Cancer - Brain Tumour Group (EORTC-BTG) surveyMaximilian J Mair, Philipp Lohmann, Norbert Galldiks, et al.
Neuro-Oncology|May 27, 2025
Postoperative radiotherapy in subtotally resected recurrent WHO grade 1 meningiomas with intermediate-/high-risk molecular profilesMaximilian Y Deng, Sybren L N Maas, Günes Anil, et al.
Nature|July 22, 2014
A vaccine targeting mutant IDH1 induces antitumour immunityTheresa Schumacher, Lukas Bunse, Stefan Pusch, et al.
Neuropathology and Applied Neurobiology|November 20, 2021
Implementation of TERT promoter mutations improve prognostication of the WHO classification in meningiomaChristian Mirian, Kathrine Grell, Tareq A Juratli, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 23, 2019
Cytotoxic T Cells and their Activation Status are Independent Prognostic Markers in MeningiomasCarmen Rapp, Steffen Dettling, Fang Liu, et al.
Neuro-Oncology|June 5, 2024
Risk factors for domain-specific neurocognitive outcome in pediatric survivors of a brain tumor in the posterior fossa-Results of the HIT 2000 trialMartin Mynarek, Anne Rossius, Anika Guiard, et al.
Neuro-Oncology Advances|June 9, 2023
Analysis of recurrence probability following radiotherapy in patients with CNS WHO grade 2 meningioma using integrated molecular-morphologic classificationMaximilian Y Deng, Felix Hinz, Sybren L N Maas, et al.
Pageof 46